The influence of TLR4 agonist lipopolysaccharides on hepatocellular carcinoma cells and the feasibility of its application in treating liver cancer

Zujiang Yu(First Affiliated Hospital of Zhengzhou University), Shen Shen(First Affiliated Hospital of Zhengzhou University)
OncoTargets and Therapy
August 1, 2015
Cited by 13


Related Papers